palbociclib
novartis,pfizer,eli lilly
['ibrance', 'breast', 'pfizer', 'novartis', 'fierce', 'biotec']
asco: pfizer's ibrance fails to extend lives in newly diagnosed breast cancer. will doctors switch gears to novartis, lilly? - fiercepharma #strategy #competitiveintelligence #marketing #pharmaceutical #healthcare #competitivemarketing #pharma #biotech 
Strategy & Competitive Marketing | Digital & Social Pharma | Life Sciences Investment | Cell & Gene Therapy | Vaccines